AP122 Insights and Controversies in Pulmonary Neoplasia
8:00–11:30 am
3 CME CREDITS
Development of the high resolution CT scan improved early detection of neoplastic lesions of the lung and pleura. This resulted in increased use of bronchoscopic and core needle biopsies, which has decreased the amount of material available for initial review. Through a series of case presentations illustrating challenging situations in the diagnosis of neoplastic lung diseases, this course will provide a practical surgical pathology update. Faculty will discuss the value of ancillary studies in facilitating diagnosis, predicting the prognosis, and projecting response to therapy, as appropriate. The session will give practical tips for generating surgical pathology reports that are easily understood by thoracic surgeons and oncologists. Upon completion of the course, participants will understand how to integrate histology, emerging molecular techniques, and clinical information in the diagnosis of pulmonary neoplasms.
You will learn to:
- Recognize histologic variants of lung carcinoma and their impact on patient treatment and prognosis
- Implement radiographic-histologic correlation in diagnosis of lung neoplasms
- Apply current recommendations in molecular diagnostics of lung carcinoma
- Utilize diagnostic ancillary testing in pulmonary neoplasms
Faculty
Philip T. Cagle, MD, FCAP
Sanja Dacic, MD, PhD, FCAP
Cosponsored by 